Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
104.54
+0.35 (0.34%)
Jun 10, 2026, 9:41 AM EDT - Market open
Encompass Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 810.8 | 759.1 | 596.6 | 463 | 365.9 | 517.2 |
Depreciation & Amortization | 336 | 327.9 | 299.6 | 273.9 | 243.6 | 219.6 |
Stock-Based Compensation | 58.5 | 56.5 | 48.3 | 50.6 | 29.2 | 29.1 |
Other Adjustments | 2.3 | 28.2 | 36.7 | 17 | 60.4 | 22.8 |
Change in Receivables | -43.7 | -15.2 | 3 | -22.4 | -16.9 | -39.5 |
Changes in Accounts Payable | -22.5 | -22.6 | 3 | 11.8 | 2.3 | 15.6 |
Changes in Accrued Expenses | 9.5 | 15.9 | 20.4 | 39.2 | -31.2 | -30.4 |
Changes in Other Operating Activities | 40 | 26.2 | -4.5 | 21.7 | 15.4 | -55.6 |
Operating Cash Flow | 1,200 | 1,176 | 1,003 | 850.8 | 705.8 | 715.8 |
Operating Cash Flow Growth | 14.01% | 17.23% | 17.87% | 20.54% | -1.40% | 1.57% |
Capital Expenditures | -735.7 | -736.4 | -642.5 | -583.1 | -584.1 | -545.7 |
Purchases of Investments | -208.5 | -184.4 | -22.5 | -23 | -35.2 | -9 |
Proceeds from Sale of Investments | 204.7 | 172.8 | 18.9 | 7.4 | - | - |
Other Investing Activities | -14.4 | -16.6 | -7.2 | -4.1 | -4.2 | 7.6 |
Investing Cash Flow | -756.2 | -764.6 | -653.3 | -602.8 | -627 | -666.3 |
Short-Term Debt Issued | 570 | 210 | 80 | 60 | 240 | 300 |
Short-Term Debt Repaid | -350 | -100 | -60 | -115 | -385 | -100 |
Net Short-Term Debt Issued (Repaid) | 220 | 110 | 20 | -55 | -145 | 200 |
Long-Term Debt Issued | - | - | 15 | 20 | 11.8 | - |
Long-Term Debt Repaid | -109.75 | -115.1 | -255.2 | -7.2 | -345.8 | -214.5 |
Net Long-Term Debt Issued (Repaid) | -109.75 | -115.1 | -240.2 | 12.8 | -334 | -214.5 |
Repurchase of Common Stock | -197.5 | -158 | -31.1 | - | - | - |
Net Common Stock Issued (Repurchased) | -197.5 | -158 | -31.1 | - | - | - |
Common Dividends Paid | -73.4 | -71.1 | -62.8 | -60.4 | -99 | -112.2 |
Other Financing Activities | -231.5 | -197 | -16.5 | -94.6 | -82.8 | -103.2 |
Financing Cash Flow | -403.3 | -431.2 | -330.6 | -197.2 | -145.7 | -240.1 |
Net Cash Flow | 60.5 | -20.2 | 18.9 | 50.8 | -66.9 | -190.6 |
Free Cash Flow | 464.4 | 439.2 | 360.3 | 267.7 | 121.7 | 170.1 |
Free Cash Flow Growth | 5.74% | 21.90% | 34.59% | 119.97% | -28.45% | -45.46% |
FCF Margin | 6.10% | 7.40% | 6.71% | 5.58% | 2.80% | 4.24% |
Free Cash Flow Per Share | 4.56 | 4.30 | 3.53 | 2.64 | 1.21 | 1.70 |
Levered Free Cash Flow | 604.45 | 172.1 | -88.5 | 73.3 | -560.7 | 3 |
Unlevered Free Cash Flow | 1,553 | 450.94 | 367.28 | 335.97 | 136.26 | 129.85 |